JP2019509985A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509985A5
JP2019509985A5 JP2018539955A JP2018539955A JP2019509985A5 JP 2019509985 A5 JP2019509985 A5 JP 2019509985A5 JP 2018539955 A JP2018539955 A JP 2018539955A JP 2018539955 A JP2018539955 A JP 2018539955A JP 2019509985 A5 JP2019509985 A5 JP 2019509985A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
item
use according
electronic monitoring
monitoring device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018539955A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019509985A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/016018 external-priority patent/WO2017136421A1/en
Publication of JP2019509985A publication Critical patent/JP2019509985A/ja
Publication of JP2019509985A5 publication Critical patent/JP2019509985A5/ja
Priority to JP2022129292A priority Critical patent/JP2022172151A/ja
Pending legal-status Critical Current

Links

JP2018539955A 2016-02-01 2017-02-01 心房細動を含む心不整脈を管理するための吸入薬物療法との電子的監視の組み合せ Pending JP2019509985A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022129292A JP2022172151A (ja) 2016-02-01 2022-08-15 心房細動を含む心不整脈を管理するための吸入薬物療法との電子的監視の組み合せ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662289473P 2016-02-01 2016-02-01
US62/289,473 2016-02-01
PCT/US2017/016018 WO2017136421A1 (en) 2016-02-01 2017-02-01 Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022129292A Division JP2022172151A (ja) 2016-02-01 2022-08-15 心房細動を含む心不整脈を管理するための吸入薬物療法との電子的監視の組み合せ

Publications (2)

Publication Number Publication Date
JP2019509985A JP2019509985A (ja) 2019-04-11
JP2019509985A5 true JP2019509985A5 (https=) 2020-03-12

Family

ID=58462619

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018539955A Pending JP2019509985A (ja) 2016-02-01 2017-02-01 心房細動を含む心不整脈を管理するための吸入薬物療法との電子的監視の組み合せ
JP2022129292A Pending JP2022172151A (ja) 2016-02-01 2022-08-15 心房細動を含む心不整脈を管理するための吸入薬物療法との電子的監視の組み合せ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022129292A Pending JP2022172151A (ja) 2016-02-01 2022-08-15 心房細動を含む心不整脈を管理するための吸入薬物療法との電子的監視の組み合せ

Country Status (13)

Country Link
US (2) US10010294B2 (https=)
EP (1) EP3411030A4 (https=)
JP (2) JP2019509985A (https=)
KR (1) KR20180102201A (https=)
CN (2) CN109069495A (https=)
AU (1) AU2017215189A1 (https=)
CA (1) CA3012333A1 (https=)
GB (2) GB2552856A (https=)
IL (1) IL260335B2 (https=)
MX (1) MX2018009248A (https=)
RU (1) RU2768748C2 (https=)
SG (2) SG10202012584UA (https=)
WO (1) WO2017136421A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069495A (zh) 2016-02-01 2018-12-21 英凯达治疗公司 电子监测联合吸入药理学疗法管理包括心房颤动在内的心律失常
AU2018266199A1 (en) 2017-05-10 2019-11-07 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
US10744087B2 (en) 2018-03-22 2020-08-18 Incarda Therapeutics, Inc. Method to slow ventricular rate
CN112533664A (zh) * 2018-06-05 2021-03-19 英凯达治疗公司 使用气雾剂诊断Brugada综合征的方法
US20210398638A1 (en) * 2018-11-27 2021-12-23 Ipsen Biopharm Limited Dosing calculator for spasticity
AU2020323594B2 (en) * 2019-08-01 2022-02-03 Incarda Therapeutics, Inc. Antiarrhythmic formulation
US11007185B2 (en) 2019-08-01 2021-05-18 Incarda Therapeutics, Inc. Antiarrhythmic formulation
CN116867483A (zh) * 2020-12-17 2023-10-10 英凯达治疗公司 用于诱导患有房性心律失常的对象的心脏复律的试剂盒和方法
CA3200432A1 (en) * 2020-12-17 2022-06-23 Incarda Therapeutics, Inc. Kits and methods for induction of cardioversion in subjects with atrial arrhythmias
EP4266919A1 (en) * 2020-12-22 2023-11-01 Philip Morris Products S.A. Aerosol-generating device with humidity sensor and humidifier
WO2025217305A1 (en) * 2024-04-10 2025-10-16 Incarda Therapeutics, Inc. Devices, kits, and methods for delivering medication via the lungs

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1004593A (en) 1911-03-25 1911-10-03 Catherine Ryan Measuring device for cutting garments.
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1016489B (it) 1974-03-18 1977-05-30 Isf Spa Inalatore
SE408265B (sv) 1975-12-12 1979-06-05 Draco Ab Anordning for koldioxiddriven endosaerosol, avsedd for inhalering
US4247066A (en) 1978-02-21 1981-01-27 General Dynamics Corporation Airfoil variable cambering device and method
IT1116047B (it) 1979-04-27 1986-02-10 Sigma Tau Ind Farmaceuti Dispositivo per la rapida inalazione di farmaci in polvere da parte di persone sofferenti di asma
DE3634952A1 (de) 1986-10-14 1988-04-21 Bayer Ag Imidazo-pyrrolo-pyridin-derivate
US4930518A (en) * 1988-09-26 1990-06-05 Hrushesky William J M Sinus arrhythmia monitor
US4962095A (en) 1989-02-15 1990-10-09 E. R. Squibb & Sons, Inc. Method of reducing pre-and post-ischemic myocardial arrhythmias and fibrillation
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
DE69230613T2 (de) 1991-07-02 2000-12-28 Inhale Inc Verfahren und vorrichtung zum abgeben von medikamenten in aerosolform
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
ATE416755T1 (de) 1994-03-07 2008-12-15 Nektar Therapeutics Verfahren und zusammensetzung für die pulmonale darreichung von insulin
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
MX9605717A (es) 1994-05-18 1998-05-31 Inhale Therapeutic Syst Metodos y composiciones para la formulacion de polvo seco de interferones.
JP3388896B2 (ja) 1994-08-08 2003-03-24 株式会社日立ユニシアオートモティブ 吸入式投薬器
US5693609A (en) 1994-11-17 1997-12-02 Eli Lilly And Company Acylated insulin analogs
ATE287703T1 (de) 1995-04-14 2005-02-15 Nektar Therapeutics Pulverförmige pharmazeutische formulierungen mit verbesserter dispergierbarkeit
US5985309A (en) 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US6503480B1 (en) 1997-05-23 2003-01-07 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
AU5719798A (en) 1996-12-31 1998-07-31 Inhale Therapeutic Systems, Inc. Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
US20020017295A1 (en) 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
AU756693B2 (en) 1997-09-29 2003-01-23 Novartis Ag Stabilized bioactive preparations and methods of use
WO1999016420A1 (en) 1997-09-29 1999-04-08 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in nebulizers
US6541479B1 (en) 1997-12-02 2003-04-01 Massachusetts College Of Pharmacy Calcium channel blockers
US7308894B2 (en) * 1998-06-03 2007-12-18 Scott Laboratories, Inc. Apparatuses and methods for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures according to appropriate clinical heuristics
US6257233B1 (en) 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
DE19835346A1 (de) 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
KR20010111564A (ko) 1998-11-12 2001-12-19 프랭크 쥐. 필키윅즈 흡입 시스템
MXPA01012246A (es) 1999-05-28 2002-08-12 Inhale Therapeutic Syst Aparato y metodo para distribuir una cantidad medida de medicamento en aerosol.
US8002700B2 (en) * 1999-12-30 2011-08-23 Medtronic, Inc. Communications system for an implantable medical device and a delivery device
CA2406206C (en) 2000-04-17 2012-03-20 Vectura Limited Improvements in or relating to formulations for use in inhaler devices
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US20040156792A1 (en) 2002-12-31 2004-08-12 Nektar Therapeutics Pharmaceutical formulation with an insoluble active agent
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US6357490B1 (en) 2000-08-22 2002-03-19 Advanced Inhalation Research, Inc. System, method and apparatus for filling containers
SE517229C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Kontinuerlig inhalator för torrt pulver
FI20002215A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
JP4119751B2 (ja) * 2000-11-28 2008-07-16 メドトロニック・インコーポレーテッド 埋め込み可能な医療装置
KR100743404B1 (ko) 2000-12-21 2007-07-30 넥타르 테라퓨틱스 폴리엔 항균제의 폐 전달
BR0208012A (pt) 2001-03-20 2004-03-02 Glaxo Group Ltd Usos de pelo menos duas drogas e um propelente hfa e de pelo menos uma composição farmaceêutica, e, inalador acondicionado para tratar asma
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
JP2005503425A (ja) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US20080038363A1 (en) 2001-05-24 2008-02-14 Zaffaroni Alejandro C Aerosol delivery system and uses thereof
WO2003026559A2 (en) 2001-09-28 2003-04-03 Kurve Technology, Inc Nasal nebulizer
US6968226B2 (en) * 2002-01-30 2005-11-22 Medtronic, Inc. Method and system for terminating an atrial arrhythmia
CN101385738A (zh) 2002-04-18 2009-03-18 Cv医药有限公司 包括给予A1腺苷激动剂以及β受体阻滞剂、钙通道阻滞剂、或强心苷的治疗心律失常的方法
EP1356762A1 (de) * 2002-04-22 2003-10-29 UbiCom Gesellschaft für Telekommunikation mbH Geräteanordnung zur Fernüberwachung von Körperfunktionen
US7607436B2 (en) 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US8245708B2 (en) 2002-05-07 2012-08-21 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
EP1515768B1 (en) 2002-05-07 2013-11-06 The State University of New York at Stony Brook Devices for targeted endobronchial therapy
US6871089B2 (en) * 2002-06-05 2005-03-22 Card Guard Technologies, Inc. Portable ECG monitor and method for atrial fibrillation detection
US20040045546A1 (en) 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
RU38570U1 (ru) 2002-12-19 2004-07-10 Главный военный клинический госпиталь им. акад. Н.Н. Бурденко Комплекс лечения нарушений сердечного ритма
WO2004100964A1 (en) 2003-04-24 2004-11-25 Aderis Pharmaceuticals, Inc. Method of treating atrial fibrillation or atrial flutter
WO2005018635A2 (en) 2003-08-07 2005-03-03 Cardiome Pharma Corp. Ion channel modulating activity i
US7967756B2 (en) * 2003-09-18 2011-06-28 Cardiac Pacemakers, Inc. Respiratory therapy control based on cardiac cycle
US20050142070A1 (en) * 2003-09-18 2005-06-30 Hartley Jesse W. Methods and systems for assessing pulmonary disease with drug therapy control
US8403865B2 (en) * 2004-02-05 2013-03-26 Earlysense Ltd. Prediction and monitoring of clinical episodes
US20070118054A1 (en) * 2005-11-01 2007-05-24 Earlysense Ltd. Methods and systems for monitoring patients for clinical episodes
EP2388036A3 (en) 2004-02-25 2013-03-13 ResMed Ltd. Cardiac monitoring and therapy using a device for providing pressure treatment of sleep disordered breathing
CA2464029A1 (en) * 2004-04-08 2005-10-08 Valery Telfort Non-invasive ventilation monitor
WO2005112957A1 (en) 2004-05-21 2005-12-01 Transave, Inc. Treatment of lung diseases and pre-lung disease conditions
US8569277B2 (en) 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20060120962A1 (en) 2004-10-12 2006-06-08 Rabinowitz Joshua D Cardiac safe, rapid medication delivery
US20070086957A1 (en) 2005-10-10 2007-04-19 Thierry Bouyssou Combination of medicaments for the treatment of respiratory diseases
ITMI20051999A1 (it) 2005-10-21 2007-04-22 Eratech S R L Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
KR20080057296A (ko) 2005-10-21 2008-06-24 머크 앤드 캄파니 인코포레이티드 칼륨 채널 억제제
CL2007002689A1 (es) 2006-09-18 2008-04-18 Vitae Pharmaceuticals Inc Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
WO2008039242A1 (en) * 2006-09-28 2008-04-03 Medtronic, Inc. Implantable medical device with sensor self-test feature
EP2077882A2 (en) 2006-10-25 2009-07-15 Nektar Therapeutics Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
EP2099295A4 (en) 2006-11-22 2010-02-24 Reliant Pharmaceuticals Inc PROPHYLAXIS AND TREATMENT OF AURICULAR FIBRILLATION WITH OMEGA-3 FATTY ACIDS
TW200840578A (en) 2006-12-15 2008-10-16 Procter & Gamble Compositions of azimilide dihydrochloride
WO2008134630A1 (en) 2007-04-30 2008-11-06 Apt Pharmaceuticals Dexrazoxane compounds for cardioprotection
US20080275036A1 (en) 2007-05-02 2008-11-06 Apt Pharmaceuticals, Inc. Prevention and treatment of cardiac conditions
US9320448B2 (en) * 2008-04-18 2016-04-26 Pacesetter, Inc. Systems and methods for improved atrial fibrillation (AF) monitoring
CA2733930A1 (en) 2008-08-14 2010-02-18 The Uab Research Foundation Anti-arrhythmia agents, methods of their use, methods of their identification, and kits therefore
WO2010022259A1 (en) 2008-08-22 2010-02-25 Milestone Pharmaceuticals Inc. Short acting benzothiazepine calcium channel blockers and uses thereof
KR20180089553A (ko) 2008-09-23 2018-08-08 라보라토리 스킨 케어, 인크. 활성제 장입된 균일하고 강성이면서 구형의 나노다공성 인산칼슘 입자 및 그의 제조 방법과 그의 용도
WO2010042658A1 (en) 2008-10-07 2010-04-15 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
AU2013248242B2 (en) * 2009-03-18 2016-08-18 Incarda Therapeutics, Inc Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
EP3552602B1 (en) 2009-03-18 2025-03-05 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
EP2605698B1 (en) * 2010-08-17 2020-04-15 University of Florida Research Foundation, Inc. Central site photoplethysmography, medication administration, and safety
ITRM20110390A1 (it) 2011-07-21 2013-01-22 Eramo Alessandra D Prodotto per stimolare la produzione endogena di mediatori dell'infiammazione.
US20140190496A1 (en) * 2012-11-28 2014-07-10 E-Nicotine Technology, Inc. Methods and devices for compound delivery
WO2014191837A2 (en) * 2013-05-06 2014-12-04 University Health Network Methods of administering dantrolene for the acute treatment of cardiac arrhythmias
GB2522727B (en) * 2013-11-26 2017-01-25 Purity Health Pharma Ltd Pulmonary delivery devices
CN109069495A (zh) 2016-02-01 2018-12-21 英凯达治疗公司 电子监测联合吸入药理学疗法管理包括心房颤动在内的心律失常
AU2018266199A1 (en) 2017-05-10 2019-11-07 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration

Similar Documents

Publication Publication Date Title
JP2019509985A5 (https=)
RU2018131232A (ru) Сочетание электронного мониторинга с ингаляционной фармакологической терапией для контроля сердечных аритмий, включая мерцательную аритмию
JP6696772B2 (ja) 非侵襲性の換気を提供するためのシステム及びフェイス・マスク
JP2011529083A5 (https=)
JP2018070616A (ja) 高濃度の一酸化窒素の投与法
JP2014514271A5 (https=)
Katz et al. Anxiety reaction in children during removal of their plaster cast with a saw
Lee et al. Torsades de pointes after ondansetron infusion in 2 patients
Mohideen et al. Basics of Management of Medical Emergencies in Dental Offi ce and Emergency Drug Kit
JP2016510040A5 (https=)
RU2010120806A (ru) Композиции для ингаляции, содержащие кислоту монтелукаст и ингибитор pde-4 или ингаляционный кортикостероид
Chrystyn et al. P154 Evaluation of Inhaler Technique Mastery for Budesonide Formoterol Spiromax® Compared with Symbicort Turbohaler® in Adult Patients with Asthma: Primary Results From the Easy Low Instruction Over Time [ELIOT] Study
Meek et al. Medicines for COPD
RU2626768C2 (ru) Способ лечения бронхиальной астмы
RU2018144594A (ru) Способ лечения синдрома дыхательной недостаточности у больных острым ишемическим инсультом
Garkhede et al. ASTHMA DISEASE AND IT'S TREATMENT COMPETITIVE OID PUMP VS NEW PUMP
Grant1 et al. Mining emergencies
Wigen-Dewey Manual Resuscitation Self-Inflating Bag-Valve-Mask Device
Katipoğlu et al. Acute Management of Spinal Cord Injury at the Out-of-Hospital and Emergency Department Settings
Yagi How the RECOVER guidelines changed Veterinary CPR.
Dresler MS15. 02 Pharmacotherapy Supports Cessation
Kocaoglu Pulmonary haemosiderosis and other toxicities following intoxication: case report
Verdu Solans Hydralazine overdose
CN106692743A (zh) 一种三臣混悬液及其制备方法
Bharathi Bronchial Thermoplasty